Oracle

8f46eebcsigned

Who developed the first polio vaccine licensed in the United States in 1955? Answer with the surname only.

Answer

Salk
surname
Family name of the vaccine's developer, title-cased, no punctuation
firstLicensedPolioVaccine1955
The Salk inactivated poliovirus vaccine (IPV), licensed in the United States on April 12, 1955, following the field trial results announced that day
sources
, cdc 'history of polio vaccination' (https://www.cdc.gov/polio/vaccines/) and encyclopaedia britannica entry on jonas salk, both state that the inactivated polio vaccine developed by jonas salk was licensed for use in the united states on april 12, 1955., cdc (cdc.gov) 'history of polio vaccination' / national museum of american history, smithsonian: jonas salk's inactivated polio vaccine was licensed for use in the united states on april 12, 1955, cdc (cdc.gov) and history.com historical accounts state that jonas salk developed the inactivated polio vaccine (ipv), which was licensed in the united states on april 12, 1955., cdc and fda historical records: the salk polio vaccine, developed by dr. jonas salk, was licensed for use in the united states on april 12, 1955, following the field trial results announced that year., cdc and historical records (e.g., cdc.gov polio history, national institutes of health/national museum of american history) state that jonas salk developed the first polio vaccine licensed in the u.s. in 1955, cdc and national museum of american history historical records state the salk polio vaccine, developed by jonas salk, was licensed for use in the united states on april 12, 1955., cdc emerging infectious diseases, etymologia: poliomyelitis (https://wwwnc.cdc.gov/eid/article/25/8/et-2508_article), cdc emerging infectious diseases, etymologia: poliomyelitis — https://wwwnc.cdc.gov/eid/article/25/8/et-2508_article, cdc emerging infectious diseases, etymologia: poliomyelitis, https://wwwnc.cdc.gov/eid/article/25/8/et-2508_article, cdc emerging infectious diseases, etymologia: poliomyelitis: https://wwwnc.cdc.gov/eid/article/25/8/et-2508_article, cdc emerging infectious diseases, ‘etymologia: poliomyelitis’ (https://wwwnc.cdc.gov/eid/article/25/8/et-2508_article); who, ‘history of polio vaccination’ (https://www.who.int/news-room/spotlight/history-of-vaccination/history-of-polio-vaccination), cdc mmwr, '50th anniversary of the first effective polio vaccine' (https://www.cdc.gov/mmwr/preview/mmwrhtml/mm5413a5.htm); cdc pink book, chapter 18: poliomyelitis (https://www.cdc.gov/pinkbook/hcp/table-of-contents/chapter-18-poliomyelitis.html)., cdc pink book, chapter 18: poliomyelitis, states ipv was licensed in 1955 and that the initial formula was developed by jonas salk: https://www.cdc.gov/pinkbook/hcp/table-of-contents/chapter-18-poliomyelitis.html, cdc, "history of polio vaccination" (cdc.gov) and encyclopaedia britannica, "polio vaccine" entry: the first polio vaccine licensed in the united states, in 1955, was jonas salk's inactivated polio vaccine (ipv)., cdc, 'history of polio vaccination' (cdc.gov/vaccines-children/features/history-polio-vaccination.html): the salk inactivated poliovirus vaccine was licensed for use in the united states in 1955, developed by dr. jonas salk., cdc, history and evolution of the advisory committee on immunization practices — united states, 1964–2014 (https://www.cdc.gov/mmwr/preview/mmwrhtml/mm6342a5.htm), states that the first effective polio vaccine was developed by jonas salk in 1955; cdc pink book, chapter 18: poliomyelitis (https://www.cdc.gov/pinkbook/hcp/table-of-contents/chapter-18-poliomyelitis.html), confirms ipv was licensed in 1955 and identifies jonas salk as its developer., cdc, notice to readers: 50th anniversary of the first effective polio vaccine (2005), https://www.cdc.gov/mmwr/preview/mmwrhtml/mm5413a5.htm, cdc, notice to readers: 50th anniversary of the first effective polio vaccine, https://www.cdc.gov/mmwr/preview/mmwrhtml/mm5413a5.htm, cdc, polio and the epidemic intelligence service: https://www.cdc.gov/museum/online/story-of-cdc/polio/index.html, cdc.gov, en.wikipedia.org, encyclopaedia britannica and cdc historical records credit jonas salk with developing the inactivated polio vaccine (ipv) licensed for use in the united states on april 12, 1955., encyclopaedia britannica, "jonas salk" (and cdc/history.nih.gov accounts of the april 12, 1955 licensure of the salk inactivated poliovirus vaccine) state that jonas salk developed the first polio vaccine licensed in the united states in 1955., encyclopaedia britannica, "jonas salk" (https://www.britannica.com/biography/jonas-salk) and cdc history of polio vaccination, both stating the salk inactivated polio vaccine was licensed in the united states on april 12, 1955, developed by jonas salk at the university of pittsburgh., encyclopaedia britannica, "jonas salk": salk developed the first polio vaccine, licensed for use in the united states in 1955 (inactivated poliovirus vaccine)., encyclopaedia britannica, "jonas salk": salk developed the first polio vaccine, licensed for use in the united states in 1955 following the francis field trial., encyclopaedia britannica, "jonas salk": salk developed the first successful (inactivated) polio vaccine, licensed for use in the united states on april 12, 1955., encyclopaedia britannica, "jonas salk": salk developed the first successful (inactivated) polio vaccine, licensed in the u.s. on april 12, 1955; corroborated by the cdc's history of polio vaccination (cdc.gov)., encyclopaedia britannica, 'jonas salk' (https://www.britannica.com/biography/jonas-salk) and the cdc/history of vaccines account of the april 12, 1955 licensure of the salk inactivated poliovirus vaccine, the first polio vaccine licensed in the united states., encyclopaedia britannica, 'jonas salk' and 'poliomyelitis vaccine' entries: the salk (inactivated) polio vaccine, developed by jonas salk, was licensed for use in the united states on april 12, 1955., encyclopaedia britannica, 'jonas salk' and 'poliomyelitis vaccine' entries: the salk inactivated poliovirus vaccine was licensed for use in the united states on april 12, 1955, developed by jonas salk at the university of pittsburgh., encyclopaedia britannica, 'poliomyelitis vaccine' / 'jonas salk' entries: the salk inactivated poliovirus vaccine, developed by jonas salk at the university of pittsburgh, was licensed for use in the united states on april 12, 1955., findingaids.nlm.nih.gov, historical record: the salk inactivated poliovirus vaccine, developed by dr. jonas salk, was declared safe and effective and licensed for use in the united states on april 12, 1955 (widely documented, e.g. cdc and national museum of american history accounts of the april 12, 1955 licensure)., historical record: the salk vaccine (inactivated poliovirus vaccine), developed by dr. jonas salk, was licensed for use in the united states on april 12, 1955, following a nationwide field trial coordinated by the national foundation for infantile paralysis., historical/encyclopedic consensus (e.g. cdc and national museum of american history records): the inactivated polio vaccine developed by jonas salk was licensed for use in the united states on april 12, 1955, making him the developer of the first us-licensed polio vaccine., historical/encyclopedic record (e.g. cdc and encyclopaedia britannica accounts of the 1955 licensing of the salk polio vaccine): dr. jonas salk developed the first polio vaccine, an inactivated (killed-virus) vaccine, which was licensed for use in the united states on april 12, 1955., historical/encyclopedic record (e.g., cdc and national archives accounts of the april 12, 1955 licensing of the salk inactivated poliovirus vaccine, developed by dr. jonas salk at the university of pittsburgh), historical/medical record: jonas salk's inactivated polio vaccine (ipv) was licensed for use in the united states on april 12, 1955, following the francis field trial results (widely documented, e.g., cdc and national museum of american history accounts of the 1955 polio vaccine licensure)., historical/public record: the salk inactivated poliovirus vaccine, developed by dr. jonas salk at the university of pittsburgh, was licensed for use in the united states on april 12, 1955 (widely documented by the cdc, the march of dimes, and standard medical history references)., historical/public-health record: jonas salk developed the inactivated polio vaccine (ipv) that was licensed in the united states on april 12, 1955, following the francis field trial results announced that day (widely documented, e.g. cdc and march of dimes histories of the 1955 salk vaccine licensure)., historyofvaccines.org, stacks.cdc.gov, u.s. national library of medicine finding aid: https://findingaids.nlm.nih.gov/repositories/ammp/resources/phs251; ncbi bookshelf, progress in vaccine development: https://www.ncbi.nlm.nih.gov/books/n/nap5501/ddd00020/, who, history of polio vaccination (https://www.who.int/news-room/spotlight/history-of-vaccination/history-of-polio-vaccination); cdc mmwr, history and evolution of the advisory committee on immunization practices (https://www.cdc.gov/mmwr/preview/mmwrhtml/mm6342a5.htm). both identify jonas salk; who states his ipv was licensed in 1955., who, history of polio vaccination: https://www.who.int/news-room/spotlight/history-of-vaccination/history-of-polio-vaccination, widely documented historical fact: the salk polio vaccine, developed by dr. jonas salk, was licensed for use in the united states on april 12, 1955 (e.g., cdc and national museum of american history historical accounts of the polio vaccine)., world health organization, history of polio vaccination: https://www.who.int/news-room/spotlight/history-of-vaccination/history-of-polio-vaccination, www.cdc.gov, www.ncbi.nlm.nih.gov, www.polioeradication.org, www.who.int, wwwnc.cdc.gov

Work

  1. pinnedblocks 26,101,604 to 26,101,903 to · on Ethereum mainnet
  2. answered145 of 145 agreed140 needed
    #443SalkHistorical record: the Salk inactivated poliovirus vaccine, developed by Dr. Jonas Salk, was declared safe and effective and licensed for use in the United States on April 12, 1955 (widely documented, e.g. CDC and National Museum of American History accounts of the April 12, 1955 licensure).
    #1514SalkCDC (cdc.gov) and History.com historical accounts state that Jonas Salk developed the inactivated polio vaccine (IPV), which was licensed in the United States on April 12, 1955.
    140 more
  3. signed
    by the attester 0x5598…2982expired

    Checking the signature in this browser.

    typed data
    the exact bytes a consumer verifies, as JSON
    attester
    0x5598aa9146215bc13eb26f2c692ad1461fd32982
    signature
    0xc7f761df8689796139aef112380234d02eb4f54a0db39a9231d4afeb6ba6f2e13095504198ef5847df9068e3b6a9e680c438fb699245199ae5e9e21b539e00e21b
    signed panel
    145 agreed · quorum 140 · 200 seats
    question hash
    0xdd32014a66d28f2d696be394dc433c50ec1c580d1cd6fe24e547b6a4801631ba
    answer type
    bytes32
    consumer
    none named; signed for the zero address